PET biomarker outperforms established risk score in predicting survival for large B-cell lymphoma patients
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 05:16 ET (31-May-2026 09:16 GMT/UTC)
Transcranial alternating current stimulation is a safe, non-invasive therapy that modulates brain rhythms to treat disorders like depression and Alzheimer's. This review explains its mechanisms, summarizes clinical evidence, and highlights the future of personalized neuromodulation.
Wayne State University and the Barbara Ann Karmanos Cancer Institute researchers have secured a substantial grant from the American Cancer Society (ACS) to establish the Digital Engagement and Cancer Outcomes (DECO) Center. The center’s goals are to better understand the impact of the digital environment and digital inclusion on outcomes and disparities among Black cancer patients, survivors and caregivers, and advance interventions that both integrate and impact hospital and community resources to improve outcomes at the individual level.
Pioneering research will examine physical, cognitive and psychological impact of a motorsport race season
New analytical methods developed at Baylor College of Medicine and collaborating institutions have increased our understanding of how bacteria manage DNA. The methods enabled researchers to uncover how the sequence, physical shape and flexibility of DNA guide the activity of an enzyme called DNA gyrase, which used to get all the credit for managing DNA. Their work uncovers that certain attributes of DNA are major players in this game. The study, which appeared in Nature Communications, has implications for antibiotic design.
Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief and even strengthen the patient-caregiver bond. Weill Cornell Medicine and University of Southern California investigators have developed and tested the web-based platform, Living Memory Home for Dementia Care Pairs (LMH-4-DCP), in a pilot trial published April 22 in JAMA Network Open.